AZD2373

AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones
Endpoints
Tue, 02/20/18 - 11:07 am
AstraZeneca
kidney disease
Ionis Pharmaceuticals
AZD2373
antisense